Hemocyte cytotoxicity analysis: Last instar Galleria mellonella (Greater wax moth) larvae (Livefoods, UK) were anaesthetised by chilling on ice for 30 min. The larvae were surface sterilised with 70% ethanol before one of the first pro-legs excised with micro-scissors. Approximately 1.5 ml of outflowing hemolymph was collected from larvae directly into 10 ml chilled supplemented Graces Insect Medium (GIM) (Gibco, Invitrogen) and mixed rapidly by inversion. The hemocyte suspension was then centrifuged at 200g for 5 minutes, the supernatant aspirated and the hemocyte pellet gently resuspended in 1 ml GIM before being made up to a final 10 ml dilution. The hemocyte suspension was arrayed into black microplates (Greiner microclear) and incubated at 28°C undisturbed for 60 minutes for cells to settle and adhere. Monolayers were washed with GIM before addition of GIM containing 100, 10 or 1 µg/ml of each of the compounds which were co-incubated with the hemocytes for 4 h. Following incubation GIM plus compounds was aspirated and replaced with GIM containing 500 nM Mitotracker CMH 2 XRos for 45 mins at 28°C (Molecular Probes, Invitrogen). Hemocyte monolayers were washed with 1X PBS and fixed with 4% paraformaldehyde for 15mins before permeabilising with 0.2% Triton X-100 in PBS for 10 mins. Cells were stained with FITC-conjugated phalloidin and Hoechst 33258 and finally washed with PBS. The plate was imaged using the IN Cell Analyzer 2000 (GE Healthcare) and analysed using the IN Cell Analyzer 1000 Workstation software. Estimates of LD 50 values were calculated using the R statistical package (R Development Core Team (2011). R: A language and environment for statistical computing. R Foundation for Statistical Computing, Vienna, Austria. ISBN 3-900051-07-0).
Double bond location determination:
Dried methanol extract prepared as described above, was extracted with 2 mL dichloromethane and concentrated to 50-100 µl. This extract was analysed on a GC/MS. In order to verify the reaction with dimethyldisulfide (DMDS) we synthesised (Z)-Nphenylethylnonadec-10-enamide (47) as internal standard and added 1 µL (25 µg) to the extract. The sample in dichloromethane (50-100µL) was treated with 100 µL DMDS and 1-2 drops of iodine solution (6% w/v in diethyl ether). The reaction took place in a standard 2 mL GC vial fitted with a teflon-lined screw-cap lid. After reaction at 55°C for 48h, the mixture was cooled and diluted with dichloromethane (500-800 µL). Iodine was removed by shaking with 500 µL of 5% (w/v) aqueous sodium thiosulfate. The organic layer was removed, and the aqueous layer was extracted with dichloromethane. The combined organic solution was dried over Na 2 SO 4 and subsequently concentrated to a small volume of 10-20 µL.
HPLC/MS analysis:
The HPLC/MS analysis of methanol extracts were performed on an Dionex UltiMate 3000 (Bruker) HPLC system with diode array detector coupled to a amaZone ionentrap mass spectrometer and an UPLC BEH C18/1.7 µm, 2.1 x 50 mm column (Waters). Separation was achieved with eluents: MeCN/0.1% formic acid and H 2 O/0.1% formic acid and gradient range from 5 to 95% in 22 min at a flow rate of 0.6 mL/min. High resolution MS were recorded with a LTQ Orbitrap Hybrid FT mass spectrometer (Thermo) an X-Bridge C18/1.7 µm RP column (Waters) using a similar gradient.
GC/MS analysis:
The GC/MS analyses of the dichloromethane extracts were carried out on a Agilent 7890A GC system, coupled to a Agilent 5975 inert GC/MS system, equipped with DB-5HT 30 m x 0.25 mm x 0,10 µm column. GC conditions: carrier gas, helium; split-flow, 10 mL/min; injector temperature, 130 °C, oven temperature 130 °C ( 2.5 min isothermal), then 5 °C/min to 240 °C, then 30 °C/min to 300 °C (5 min isothermal), then 30 °C/min to 130 °C for 1 min; mass range 40-500 amu; EI, 70 eV. The molecular ions (M + ) and fragmentations are given as m/z.
Synthesis and 1 H and 13 C NMR characterisation N-(2-phenylethyl)butanamide (30)
The compound was synthesised as described.
2-Methyl-N-(2-phenylethyl)butanamide (32)
A solution of phenethylamine (423 µl, 406 mg, 3.33 mmol) in 2 ml CH 2 Cl 2 was cooled to 0 °C. 2-Methylbutyric acid chloride (250 µl, 243 mg, 2.02 mmol, 0.61 eq.) was added and the solution was stirred at room temperature over night. The mixture was washed with 5 % NaHCO 3 , 1 M HCl and brine, dried over Na 2 SO 4 and evaporated to dryness. The raw product was purified by column chromatography (flash, SiO 2 
N-(2-phenylethyl)decanamide (8)
A solution of phenethylamine (129 µl, 124 mg, 1.02 mmol) in 10 ml CH 2 Cl 2 was cooled to 0 °C. Decanoyl chloride (218 µl, 200 mg, 1.02 mmol, 1 eq.) was added and the solution was stirred at room temperature over night. The white precipitate was filtrated and recrystallized in hexane. 176 mg (0.639 mmol, 63 %) of the white crystalline amide was obtained. 18 (sh, 21H, 10-H -19-H 
N-(2-phenylethyl)octadecanamide (33)
The compound was synthesised as described. 
N-(2-phenylethyl)eicosanamide (34)
To a solution of arachidic acid (313 mg, 1.02 mmol) in 10ml CH 2 Cl 2 , TBTU (353 mg, 1.10 mmol, 1.10 eq.) was added and the mixture cooled to 0 °C. After dropwise addition of DIPEA (680 µl, 517 mg, 4.00 mmol, 4 eq.) the solution was stirred for 10 min at room temperature before phenethylamine (129 µl, 124 mg, 1.02 mmol, 1 eq.) was added. The mixture was stirred over night. Ammonium chloride solution was added and the aquatic layer washed three times with CH 2 Cl 2 . The combined organic layers were dried over Na 2 SO 4 and all volatile compounds were removed. 1 (C-7), 139.0 (C-4), 128.8, 128.6 (C-2, C-3), 126.5 (C-1) , 40.5 (C-6), 36.9 (C-5), 35.7 (C-8), 31.9, 30.9, 29.7, 29.7, 29.6, 29.5, 29.4, 29.3 (14C: C-10 -C-24) , 25.7 (C-9), 22.7 (C-25), 14.1 (C-26).
N-(2-phenylethyl)docosanamide (35)
A solution of phenethylamine (129 µl, 124 mg, 1.02 mmol) in 10 ml CH 2 Cl 2 was cooled to 0 °C. Docosanoyl chloride (365 mg, 1.02 mmol, 1 eq.) was added and the solution was stirred at room temperature over night. 32 (m, 2H, 2-H), 7.25 (m, 1H, 1-H), 7.20 (m, 2H, 3-H 83 mmol) oleoyl chloride were added to a 2 ml microwave vial and dissolved in 2 ml 1,2-dichlorethane. 0.1 g (0.83 mmol) 2-phenylethylamine was added and the vial was sealed. The reaction was performed in a Biotage Initiator microwave oven for 25 min at 90 °C and 70 W. The crude product was dissolved in 2 ml CH 2 Cl 2 and purified with flash chromatography using hexane/ethyl acetate gradient. The compound had identical properties as described in the literature. 
N-(2-(1H-indol-3-yl)ethyl)hexanamide (38)
A solution of tryptamine hydrochloride (100 mg, 0.508 mmol) in 2ml CH 2 Cl 2 was cooled to 0 °C and treated with DIPEA (86µl, 65.7mg, 0.508 mmol, 1eq.). Hexanoylchloride (70µl, 68.3 mg, 0.508 mmol, 1eq.) was added and the solution was stirred at room temperature over night. The mixture was washed with 5% NaHCO 3 , 1M HCl and brine, dried over Na 2 SO 4 and evaporated to dryness. The raw product was purified by column chromatography (flash, SiO 2 , hexane/ethyl acetate) to yield 35 mg (0.136 mmol, 27 %) of the white crystalline amide. The compound had identical properties as described in the literature. 6 
N-(2-(1H-indol-3-yl)ethyl)octanamide (39)
